Clinical Trial Update: Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE) [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating the efficacy and safety of Divozilimab in patients with Neuromyelitis Optica Spectrum Disorders (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorders

Drugs mentioned

• Divozilimab (Divozilimab)

Snippet

Sponsor: Biocad | Conditions: Neuromyelitis Optica Spectrum Disorders | Phase 3 | Status: ACTIVE_NOT_RECRUITING